Feeds › Insider trades
Insider trades
Open-market buys and sells by officers, directors and 10% owners, from SEC Form 4. Usually filed within two business days.
About this data
- What it is
- When a company's officers, directors or owners of more than 10% buy or sell its stock, they must report the trade to the SEC on Form 4. This feed shows purchases and sales on the open market; stock grants, option exercises and shares withheld for tax are left out.
- Who files it
- The insider, usually through the company, within two business days of the trade.
- How current
- We collect new filings throughout the day on SEC business days.
- Worth knowing
- Sales are often routine: insiders sell to diversify, to pay taxes, or under a 10b5-1 plan set up months in advance. A purchase with their own money is less common, which is why many investors pay closer attention to it.
All of this comes from public filings.
Source and freshness · Information, not investment advice (disclaimer).
Open-market trades per day, last 30 days
Purchases Sales
By trade date. Insiders have two business days to file, so the most recent days fill in later.
Latest open-market insider trades
Showing: ticker CVLG
| Traded | Insider | Company | Type | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| Jun 1, 2026 | Joey Ballard EVP, Chief People & Safety Off | CVLG Covenant Logistics Group, Inc. | Sale | 4,000 | $40.15 | $160.6K Sale | Form 4 ↗ |
| May 27, 2026 | Joey B. Hogan Director | CVLG Covenant Logistics Group, Inc. | Sale | 12,800 | $39.18 | $501.5K Sale | Form 4 ↗ |
| May 26, 2026 | Joey Ballard EVP, Chief People & Safety Off | CVLG Covenant Logistics Group, Inc. | Sale | 3,718 | $38.00 | $141.3K Sale | Form 4 ↗ |
| May 22, 2026 | Joey Ballard EVP, Chief People & Safety Off | CVLG Covenant Logistics Group, Inc. | Sale | 4,282 | $37.40 | $160.1K Sale | Form 4 ↗ |
| Apr 29, 2026 | D. Michael Kramer Director | CVLG Covenant Logistics Group, Inc. | Sale | 2,650 | $34.72 | $92.0K Sale | Form 4 ↗ |
| Apr 28, 2026 | Joey B. Hogan Director | CVLG Covenant Logistics Group, Inc. | Sale | 14,700 | $34.76 | $511.0K Sale | Form 4 ↗ |
| Apr 20, 2026 | James S. Grant III EVP and CFO | CVLG Covenant Logistics Group, Inc. | Sale | 22,388 | $30.75 | $688.4K Sale | Form 4 ↗ |
| Feb 20, 2026 | Jacqueline F. Parker 10% owner | CVLG Covenant Logistics Group, Inc. | Sale | 17,948 | $28.98 | $520.1K Sale | Form 4 ↗ |
| Feb 20, 2026 | Jacqueline F. Parker 10% owner | CVLG Covenant Logistics Group, Inc. | Sale | 12,452 | $29.47 | $367.0K Sale | Form 4 ↗ |
| Feb 19, 2026 | Jacqueline F. Parker 10% owner | CVLG Covenant Logistics Group, Inc. | Sale | 55,000 | $29.38 | $1.6M Sale | Form 4 ↗ |
| Feb 18, 2026 | Jacqueline F. Parker 10% owner | CVLG Covenant Logistics Group, Inc. | Sale | 65,000 | $29.34 | $1.9M Sale | Form 4 ↗ |
| Feb 17, 2026 | David Ray Parker Chairman and CEO, Director, 10% owner | CVLG Covenant Logistics Group, Inc. | Sale | 3,667 | $28.85 | $105.8K Sale | Form 4 ↗ |
| Feb 17, 2026 | David Ray Parker Chairman and CEO, Director, 10% owner | CVLG Covenant Logistics Group, Inc. | Sale | 96,333 | $29.70 | $2.9M Sale | Form 4 ↗ |
| Feb 13, 2026 | David Ray Parker Chairman and CEO, Director, 10% owner | CVLG Covenant Logistics Group, Inc. | Sale | 15,000 | $28.46 | $426.9K Sale | Form 4 ↗ |
| Feb 12, 2026 | David Ray Parker Chairman and CEO, Director, 10% owner | CVLG Covenant Logistics Group, Inc. | Sale | 1,000 | $27.02 | $27.0K Sale | Form 4 ↗ |
| Feb 12, 2026 | David Ray Parker Chairman and CEO, Director, 10% owner | CVLG Covenant Logistics Group, Inc. | Sale | 2,770 | $27.76 | $76.9K Sale | Form 4 ↗ |
| Feb 12, 2026 | David Ray Parker Chairman and CEO, Director, 10% owner | CVLG Covenant Logistics Group, Inc. | Sale | 16,230 | $29.36 | $476.5K Sale | Form 4 ↗ |
| Feb 11, 2026 | Jacqueline F. Parker 10% owner | CVLG Covenant Logistics Group, Inc. | Sale | 10,707 | $29.23 | $313.0K Sale | Form 4 ↗ |
| Feb 11, 2026 | Jacqueline F. Parker 10% owner | CVLG Covenant Logistics Group, Inc. | Sale | 16,693 | $29.42 | $491.1K Sale | Form 4 ↗ |
| Feb 10, 2026 | Jacqueline F. Parker 10% owner | CVLG Covenant Logistics Group, Inc. | Sale | 4,798 | $28.57 | $137.1K Sale | Form 4 ↗ |
| Feb 10, 2026 | Jacqueline F. Parker 10% owner | CVLG Covenant Logistics Group, Inc. | Sale | 15,202 | $28.61 | $434.9K Sale | Form 4 ↗ |
| Feb 10, 2026 | Jacqueline F. Parker 10% owner | CVLG Covenant Logistics Group, Inc. | Sale | 50,000 | $29.23 | $1.5M Sale | Form 4 ↗ |
| Feb 9, 2026 | Jacqueline F. Parker 10% owner | CVLG Covenant Logistics Group, Inc. | Sale | 56,000 | $28.66 | $1.6M Sale | Form 4 ↗ |
| May 21, 2025 | D. Michael Kramer Director | CVLG Covenant Logistics Group, Inc. | Sale | 2,200 | $22.80 | $50.2K Sale | Form 4 ↗ |
| Jan 28, 2025 | Matisse Long Chief Accounting Officer | CVLG Covenant Logistics Group, Inc. | Sale | 2,114 | $28.96 | $61.2K Sale | Form 4 ↗ |
| Nov 12, 2024 | Joey B. Hogan Director | CVLG Covenant Logistics Group, Inc. | Sale | 8,700 | $60.83 | $529.2K Sale | Form 4 ↗ |
| Nov 12, 2024 | Bradley A. Moline Director | CVLG Covenant Logistics Group, Inc. | Sale | 3,000 | $60.47 | $181.4K Sale | Form 4 ↗ |
| Nov 11, 2024 | Bradley A. Moline Director | CVLG Covenant Logistics Group, Inc. | Sale | 7,000 | $59.64 | $417.5K Sale | Form 4 ↗ |
28 items, most recent first (up to 50). Every row links to its original filing. Updated Nov 15, 2026, 5:39 PM EST.
Download CSV The rows of this feed, with the filters above. A download holds at most 10,000 rows; narrow the filters to get a smaller slice.
Other feeds: Congressional trades · Executive-branch trades · Bills in Congress · Roll-call votes · Corporate PAC donations · Lobbying · Capitol Hires · Lobbying and contracts · Government contracts · Planned insider sales · Executive pay · Ownership stakes (13D / 13G) · Institutional holdings (13F) · Short interest · Fails to deliver · Daily short volume · Wikipedia page views · App store ratings · H-1B visa applications · Stock splits · 8-K events · IPO filings · Deals · Private placements (Form D) · Merger clearances (HSR) · Layoff notices (WARN) · SEC enforcement · Patents · Clinical trial updates · FDA approvals and clearances